Movatterモバイル変換

[0]ホーム
URL:

Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Elsevier Science full text link Elsevier Science Free PMC article
Full text links

Actions

Review
.2014 Feb 27;97(1):2-8.
doi: 10.1016/j.lfs.2013.07.023. Epub 2013 Aug 2.

Bath salts and synthetic cathinones: an emerging designer drug phenomenon

Affiliations
Review

Bath salts and synthetic cathinones: an emerging designer drug phenomenon

Christopher L German et al. Life Sci..

Abstract

Synthetic cathinones are an emerging class of designer drugs abused for psychostimulant and hallucinogenic effects similar to cocaine, methylenedioxymethamphetamine (MDMA), or other amphetamines. Abuse of synthetic cathinones, frequently included in products sold as 'bath salts', became prevalent in early 2009, leading to legislative classification throughout Europe in 2010 and schedule I classification within the United States in 2011. Recent pre-clinical and clinical studies indicate that dysregulation of central monoamine systems is a principal mechanism of synthetic cathinone action and presumably underlie the behavioral effects and abuse liability associated with these drugs. This review provides insight into the development of synthetic cathinones as substances of abuse, current patterns of their abuse, known mechanisms of their action and toxicology, and the benefits and drawbacks of their classification.

Keywords: Bath salts; Designer drugs; MDPV; Mephedrone; Methylone; Stimulants; Synthetic cathinone.

© 2013.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest:

All authors declare no conflicts of interest

Figures

Figure 1
Figure 1
Chemical structures of dopamine, the synthetic cathinones, and closely related stimulants.
See this image and copyright information in PMC

References

    1. Anti-Drug Abuse Act of 1986. United States of America. 1986
    1. Aarde SM, Angrish D, Barlow DJ, Wright MJ, Jr, Vandewater SA, Creehan KM, et al. Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar rats. Addiction biology. 2013 - PMC - PubMed
    1. Addiction EMCfDaD. Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances. Luxembourg: The Publications Office of the European Union. 2011:193.
    1. Adebamiro A, Perazella MA. Recurrent acute kidney injury following bath salts intoxication. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2012;59:273–275. - PubMed
    1. Angoa-Perez M, Kane MJ, Briggs DI, Francescutti DM, Sykes CE, Shah MM, et al. Mephedrone does not damage dopamine nerve endings of the striatum, but enhances the neurotoxicity of methamphetamine, amphetamine, and MDMA. Journal of neurochemistry. 2012a - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full text links
Elsevier Science full text link Elsevier Science Free PMC article
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.

[8]ページ先頭
©2009-2026 Movatter.jp